APSR logo
Asian 
Pacific 
Society of 
Respirology

2017 APSR Congress

Scientific Programme

Sunday 26 November 2017

  • 08:30 - 10:00

    Clinical Respiratory Medicine: Clinical cases

    Room: Cockle Bay 1
    • 08:30 - 08:50

      Doctor, my back is so painful

      Speaker: Thomas Mok, Hong Kong
    • 08:50 - 09:05

      Singing myself awake

      Speaker: Thomas Mok, Hong Kong
    • 09:05 - 09:25

      Survival creates novel challenges

      Speaker: Thomas Mok, Hong Kong
    • 09:25 - 09:50

      Put away the binoculars

      Speaker: Thomas Mok, Hong Kong
    • 09:50 - 10:00

      Spot diagnosis

      Speaker: Thomas Mok, Hong Kong
  • COPD 2: Predicting progression and therapeutic responses in COPD

    Room: Darling Harbour Theatre
    • 08:30 - 09:00

      Cells and cytokines

      Speaker: Ian Yang, AU
    • 09:00 - 09:30

      Airway and lung imaging

      Speaker: Greg King, AU
    • 09:30 - 10:00

      Clinical markers

      Speaker: Alberto Papi, Italy
  • This program currently is under development and is subject to change Interstitial Lung Disease 2: Improving diagnosis and treatment of NSIP

    Room: Cockle Bay 2
    • 08:30 - 09:10

      Mini-MDT - diagnosis/imaging

      Speaker: Michael Jones, Wendy Cooper & Lauren Troy, NSW
    • 09:10 - 09:35

      When steroids are not working; second line therapies for NSIP

      Speaker: Margaret Wilsher, NZ
    • 09:35 - 10:00

      Emerging understanding of NSIP

      Speaker: Takafumi Suda, Japan
  • Oral Presentations: Asthma 2

    Room: E3.1
    • 08:30 - 08:40

      Ghrelin Protects against Airway Eosinophilic Inflammation in Asthma

      Speaker: Hironobu Tsubouchi, Japan
    • 08:40 - 08:50

      Obesity, Defined by Body Mass Index of no Less than 25 kg/m2, is a Risk Factor for Poor Asthma Control in East-Asian Female Populations

      Speaker: Masako To, Japan
    • 08:50 - 09:00

      Free Fatty Acid Receptors 1 and 4 are Novel Bronchodilator Targets for Asthma

      Speaker: Ralph Angeles, AU
    • 09:00 - 09:10

      Associations between Nutrient-Based Dietary Patterns and Lung Function in Middle-Aged and Older Australian Adults

      Speaker: Stephanie Byrne, AU
    • 09:10 - 09:20

      Analysis of T Cell-Induced Bronchoconstriction in Murine Asthma Model

      Speaker: Akio Mori, Japan
    • 09:20 - 09:30

      Enzyme Markers of Neutrophilic Segment of Bronchial Inflammation at Osmotic Airway Hyperresponsiveness in Patients with Asthma

      Speaker: Juliy Perelman, Russia
    • 09:30 - 09:40

      Effects of the Addition of Tiotropium Versus Montelukast on Airway Inflammation and Remodeling in Symptomatic Asthma

      Speaker: Makoto Hoshino, Japan
    • 09:40 - 09:50

      Therapeutic Effects of Histone Deacetylase Enzyme 8 Inhibitors (HDAC8I) in a Murine Asthma Model

      Speaker: Yuan Ren, China
  • Oral Presentations: Critical Care Medicine

    Room: E3.2
    • 08:30 - 08:45

      Clinical Difference Between Direct and Indirect Causes of Acute Respiratory Distress

      Syndrome: A Retrospective Cohort Study of 216 Patients

      Speaker: Keisuke Anan, Japan
    • 08:45 - 08:55

      Efficacy of Continuous Blood Purification on Patients with Severe Acute Pancreatitis Associated Acute Respiratory Distress Syndrome

      Speaker: Feihu Zhou, China
    • 08:55 - 09:10

      Ventilatory Dyssynchrony in Mechanically Ventilated Patients: Is it a Problem?

      Speaker: Peter Sottile, US
    • 09:10 - 09:20

      Efficacy and Safety of Acetazolamide for Hypercapnic Respiratory Failure Associated with Metabolic Alkalosis in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Trials

      Speaker: Carla Emille Barbon, Philippines
    • 09:20 - 09:30

      The Role of CIAP2 in Avian Influenza A (H7N9) Induced Acute Lung Injury Through Inducing RIPK1/3 -Dependent Necroptosis

      Speaker: Chu Qin, China
    • 09:30 - 09:40

      Induced Pluripotent Stem Cells Prevent Endothelial Cell Leakage via TIMP-1 to Reduce Fak/Snail Pathway in Sepsis-Induced Acute Lung Injury

      Speaker: Vincent Yi-Fong Su, Taiwan
    • 09:40 - 09:50

      MIR-34B-5P Inhibition Alleviates Inflammatory Response and Apoptosis via Targeting Progranulin in Acute Lung Injury Induced by Lipopolysaccharide

      Speaker: Zhongliang Guo, China
    • 09:50 - 10:00

      Pleural Research in Intensive Care (Prince-1) a Prospective Observational Study of Pleural Effusion Management

      Speaker: Portia Smallbone, AU
  • Oral Presentations: Lung Cancer 2

    Room: E3.4
    • 08:30 - 08:40

      Examination of the Rate of Quitting to Smoke among Smoker Patients who Underwent Lung Cancer Operation

      Speaker: Takaharu Kiribayashi, Japan
    • 08:40 - 08:50

      Update from the Lungscreen WA Project - a Feasability Study of Low-Dose CT Lung Cancer Screening of High-Risk Ever Smokers in Australia

      Speaker: Kuan Pin Lim, AU
    • 08:50 - 09:00

      Protocol for the International Lung Screen Trial (ILST): A Cohort Study to Define LDCT Screening Selection Criteria and Validate the Pancan Nodule Management Algorithm

      Speaker: Kuan Pin Lim, AU
    • 09:00 - 09:10

      Prediction Modeling using Routine Clinical Parameters to Stratify Survival in Mesothelioma Patients Undergoing Surgery

      Speaker: Edward Harris, AU
    • 09:10 - 09:20

      Lung Cancer in the Eastern Part of Libya

      Speaker: Khalid A Gaber, Libya
    • 09:20 - 09:30

      A Rare Case of Concomitant Medullary Thymoma with Multidrug-Resistant

      Tuberculosis

      Speaker: Achmad Gozali, Indonesia
    • 09:30 - 09:40

      Combined use of a Laryngeal Mask Airway During Extubation Reduces the Incidence of Postoperative Pulmonary Fistula in Patients Undergoing Lung Cancer Surgery

      Speaker: Hikaru Watanabe, Japan
    • 09:40 - 09:50

      Comparison of Re-Biopsy Successful Rate among Procedures and Sequential Change of EBUS Image

      Speaker: Kei Morikawa, Japan
  • Oral Presentations: Tuberculosis 3

    Room: E3.10
    • 08:30 - 08:40

      A Cluster Randomised Controlled Trial of Contact Investigation for the Detection of Tuberculosis: The Act2 Trial

      Speaker: Greg Fox, AU
    • 08:40 - 08:50

      High Prevalence of Latent Tuberculosis Infection among Healthcare Workers with History of Contact with Tuberculosis Patient in High Burden Tuberculosis Hospital

      Speaker: Rinaldy Lubis, Indonesia
    • 08:50 - 09:00

      Tuberculosis Disease among Healthcare Workers: Clinical Characteristics, Drug Resistance and Treatment Outcomes in Chiang Mai University Hospital, Thailand

      Speaker: Juthamas Inchai, Thailand
    • 09:00 - 09:10

      Treatment Outcomes of MDR-TB and Referral Networks in an Out-Patient Private-Initiated Programmatic Management for Drug Resistant Tuberculosis (PMDT) Facility

      Speaker: Victoria Dalay, Philippines
    • 09:10 - 09:20

      To Assess Treatment Outcome of Multidrug Resistant Tuberculosis in Japan - analysis of Japan TB Surveillance Data

      Speaker: Lisa Kawatsu, Japan
    • 09:20 - 09:30

      Analysis of Treatment Duration for Multidrug Resistant Tuberculsis Patients in Japan

      Speaker: Kazuhiro Uchimura, Japan
    • 09:30 - 09:40

      Multidrug-Resistant Tuberculosis Treatment Outcome: Tertiary Center Experience

      Speaker: Syazatul Syakirin Sirol Aflah, Malaysia
    • 09:40 - 09:50

      Relapse of Tuberculosis among Patients Completing Treatment in Vietnam: A Nested Case-Control Study

      Speaker: Jessica Bestrashniy, AU
    • 09:50 - 10:00

      Study of Diagnostic Utility of Xpert MTB/RIF Test on Pleural Fluid in the Evaluation of Patients Presenting with Pleural Tuberculosis in Nepal

      Speaker: Deebya Raj Mishra, Nepal
  • 10:00 - 10:30

    Morning Tea and Exhibition Viewing

    Room: Exhibition Hall
  • 10:30 - 11:30

    Plenary: Memorial Lecture: Michiyoshi Harasawa Research Award

    Room: Darling Harbour Theatre
    • 10:30 - 10:35

      Introduction

    • 10:35 - 11:20

      Respiratory research using cellular, molecular and physiologic approaches Speaker: Takahide Nagase, Japan

    • 11:20 - 11:30

      Award presentation

  • 11:30 - 13:00

    Asthma 2: Obesity, diet and asthma

    Room: Darling Harbour Theatre
    • 11:30 - 12:00

      Asthma, health literacy and Maori

      Speaker: Tristram Ingham, NZ
    • 12:00 - 12:30

      Obesity in severe asthma - cause or co-morbidity?

      Speaker: Celeste Porsbjerg, Denmark
    • 12:30 - 13:00

      Obesity and asthma: Investigating the roles of diet, exercise and adiposity

      Speaker: Hayley Scott, AU
  • Critical Care 2: Managing Multiple Organ Dysfunction Syndrome

    Room: Cockle Bay 2
    • 11:30 - 11:55

      Using ultrasound to optimise fluid management in MODS

      Speaker: Suthaporn Lumlertgul, Thailand
    • 11:55 - 12:20

      Optimal management of nutrition acutely and in recovery

      Speaker: Hayden White, AU
    • 12:20 - 12:45

      Muscle wasting and weakness in ICU: causes, mitigation, management

      Speaker: Linda Denehy, AU
    • 12:45 - 13:00

      Optimising post-ICU rehabilitation

      Speaker: Marc Moss, US
  • Tuberculosis: Drug-resistant TB

    Room: Cockle Bay 1
    • 11:30 - 12:00

      Impact assessment of the roll-out of new TB diagnostics

      Speaker: Charles Yu, Philippines
    • 12:00 - 12:30

      MDR TB new TB regimens

      Speaker: Erlina Burhan, Indonesia
    • 12:30 - 13:00

      Systems solutions to resistance development

      Speaker: Greg Fox, AU
  • Oral Presentations: Late Breaking

    Room: E3.1
    • 11:30 - 11:40

      Airway Closure and Rate of Derecruitment Measured by the Forced Oscillation Technique is Elevated in Subjects with Asthma

      Speaker: Kris Nilsen, AU
    • 11:40 - 11:50

      Forced Oscillation Technique as a Predictor of Exercise Tolerance in COPD

      Speaker: Akito Yamamoto, Japan
    • 11:50 - 12:00

      Assessing Direct Switch to Indacaterol/Glycopyrronium from Salmeterol/Fluticasone in Moderate to Severe Symptomatic COPD Patients: The Flash Study

      Speaker: Dina Diaz, Philippines
    • 12:00 - 12:10

      A Novel Quantitative-CT/ FEV1 Approach of Phenotyping COPD to Predict Mortality

      Speaker: Li Cher Loh, Malaysia
    • 12:10 - 12:20

      Respect-Meso: An International Multicentre non-Blinded Randomized Controlled Trial to Assess the Impact of Regular Early Specialist Palliative Care in Malignant Pleural Mesothelioma

      Speaker: Fraser Brims, AU
    • 12:20 - 12:30

      Prevalence and Comorbidities of Obstructive Sleep Apnoea in the Busselton Healthy Ageing Study (BHAS)

      Speaker: Jordan Cunningham, AU
  • Oral Presentations: Lung Cancer 3

    Room: E3.10
    • 11:30 - 11:40

      Common and Uncommon EGFR Mutations Analysis in Cytology and Plasma Samples of Treatment-Naive Lung Cancer Patients

      Speaker: Ahmad Utomo, Indonesia
    • 11:40 - 11:50

      Kras Mutation in EGFR Wild Type Indonesian Lung Cancer Patient

      Speaker: Najmiatul Masykura, Indonesia
    • 11:50 - 12:05

      Risk in High-Risk Populations: Moving CT Screening Beyond the Search for a Potential Lung Cancer

      Speaker: Matthew Kinsey, US
    • 12:05 - 12:15

      Importance of the Preoperative Neutrophil/Lymphocyte Ratio and Prognostic Nutritional Index for Pathological-Stage I Lung Cancer Patients

      Speaker: Isamu Watanabe, Japan
    • 12:15 - 12:25

      Serum CEA And CYFRA Responses as Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients

      Speaker: Akihiro Yoshimura, Japan
    • 12:25 - 12:35

      PD-L1 TPS Analysis in Real-World Clinical Practice: Evaluation of Specimens Obtained by Respiratory Endoscopic Biopsy

      Speaker: Midori Tanaka, Japan
    • 12:35 - 12:50

      The Efficacy and Safety of Carboplatin and Weekly Paclitaxel Combination Therapy for Previously Treated Small Cell Lung Cancer Patients with Interstitial Lung Disease

      Speaker: Ryo Itotani, Japan
  • Oral Presentations: Pulmonary Circulation

    Room: E3.4
    • 11:30 - 11:40

      Two Cases of Pulmonary Hypertension Associated with Chronic Myeloproliferative Disorders

      Speaker: Minoru Inomata, Japan
    • 11:40 - 11:50

      TNF-A Increases Vasoreactivity of Intrapulmonary Arteries in Mouse Precision Cut Lung Slices

      Speaker: Emma Lamanna, AU
    • 11:50 - 12:00

      Dynamic Changes of Macrophage M1/M2 Polarization in Monocrotaline-Induced Pulmonary Arterial Hypertension

      Speaker: Yong Fan, China
    • 12:00 - 12:10

      Bio-Distribution of EPCS in Disease and the Potential Role of Exosomes in Cell Therapy for Pulmonary Vascular Diseases

      Speaker: Rebecca Harper, AU
    • 12:10 - 12:20

      Real-Life Versus Clinical Trial Patients in Pulmonary Arterial Hypertension: An Analysis from the PHSANZ Registry

      Speaker: Nicole Roche, AU
    • 12:20 - 12:30

      Outcomes of Idiopathic Pulmonary Arterial Hypertension in the Era of Combination Therapy: A Report from the PHSANZ Registry

      Speaker: Jamal Al-Aghbari, AU
    • 12:30 - 12:40

      Long-Term Follow-Up in Serum Brain Natriuretic Peptide after Pulmonary Lobectomy for Lung Cancer

      Speaker: Mitsuhiro Kamiyoshihara, Japan
    • 12:40 - 12:55

      Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as predictive markers for DVT

      Speaker: Jason Mouabbi, US
  • Poster Session

    Room: Exhibition Hall
  • 13:00 - 14:00

    Lunch and Exhibition Viewing

    Room: Exhibition Hall
    • 14:00 - 15:30

      Bronchoscopy and Interventional Techniques 2: Applications of cryobiopsy

      Room: Cockle Bay 2
    • 14:00 - 14:10

      Introduction to cryobiopsy

      Speaker: Jonathan Williamson, AU
    • 14:10 - 14:20

      Cryobiopsy for central endobronchial lesions

      Speaker: Alvin Ing, AU
    • 14:20 - 14:30

      Radial EBUS guided cryobiopsy for peripheral lesions

      Speaker: Taj Saghaie, AU
    • 14:30 - 15:00

      Cryobiopsy in ILD

      Speaker: Venerino Poletti, Italy
    • 15:00 - 15:30

      Cryobiopsy for pleural pathology

      Speaker: Martin Phillips, AU
  • Pulmonary Circulation: Current topics in mechanisms and treatment for pulmonary hypertension

    Room: Cockle Bay 1
    • Current status of diagnosis and treatment for PAH in Japan

      Speaker: Yuichi Tamura, Japan
    • Present status and issues for treating PH associated with respiratory diseases

      Speaker: Yoshiteru Morio, Japan
    • Molecular mechanisms and novel treatment strategies for PAH

      Speaker: Rebecca Harper, AU
  • Respiratory Infections (Non-TB) 2: Microbiome

    Room: Darling Harbour Theatre
    • 14:00 - 14:30

      What is the microbiome and how is it assessed?

      Speaker: Phil Hansbro, AU
    • 14:30 - 15:00

      Dietary metabolites and novel GPCRs for asthma pathogenesis

      Speaker: Charles Mackay, Australia
    • 15:00 - 15:30

      Prediction of asthma and COPD using blood microbiome analysis

      Speaker: Yoon Keun Kim, Sth Korea
  • Oral Presentations: Asthma 3

    Room: E3.10
    • 14:00 - 14:15

      Identifying a novel therapeutic strategy for asthma: Targeting airway epithelial cell restitution

      Speaker: Thomas Iosifidis, AU
    • 14:15 - 14:25

      A Novel Peptide from the Liver Fluke Fasciola Hepatica Inhibits the Mixed Granulocytic Airway Inflammation in a Mouse Model of Allergic Asthma

      Speaker: Venkata Sita Rama Raju Allam, AU
    • 14:25 - 14:35

      The Role of Mitochondrial Fusion in the Pathogenesis of Severe Asthma with Fungal Sensitization

      Speaker: So Ri Kim, South Korea
    • 14:35 - 14:45

      Airway Epithelial Phosphoinositide 3-Kinase Delta Contributes to the Modulation of Fungi-Induced Innate Immune Response

      Speaker: Yong Chul Lee, South Korea
    • 14:45 - 14:55

      House Dust Mite Directly Induces Free Radical Production and DNA Damage, and Weakens Antioxidant Defense in Human Bronchial Epithelial Cells

      Speaker: Wai Shiu Fred Wong, Singapore
    • 14:55 - 15:05

      Efferocytosis of Apoptotic Granulocytes by Monocyte-Derived Macrophages in Adults with Asthma

      Speaker: Melanie Erriah, AU
    • 15:05 - 15:15

      Tweak and TGF-B Induced Chemokine Production in Human Bronchial Epithelial Cells During Epithelial Mesenchymal Transition

      Speaker: Kei Matsuno, Japan
    • 15:15 - 15:25

      Identification of Novel Genetic Regulations of Asthmatic Airway Epithelium, using Next-Generation Sequencing Data and Bioinformatics Approaches

      Speaker: Chau-Chyun Sheu, Taiwan
  • Oral Presentations: COPD 4

    Room: E3.1
    • 14:00 - 14:10

      The Prevalence of Reduced TLCO and the Emphysema Index in Smokers with Normal Spirometry

      Speaker: Timothy Cheung, AU
    • 14:10 - 14:20

      Spirometric Indices do not Detect Mismatch between Ventilation and Perfusion in COPD

      Speaker: Marika Bajc, Sweden
    • 14:20 - 14:30

      Muscle Echo Intensity Correlates with Physical Activity in Patients with Stable COPD

      Speaker: Kazuki Okura, Japan
    • 14:30 - 14:40

      Study of Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease

      Speaker: Hiroyuki Ohbayashi, Japan
    • 14:40 - 14:50

      Home-Based Rehabilitation for COPD using Minimal Resources: An Economic Evaluation

      Speaker: Angela Burge, AU
    • 14:50 - 15:00

      Increasing Light Physical Activity and Decreasing Sedentary Time in People With Chronic Obstructive Pulmonary Disease - a Preliminary Study

      Speaker: Janet Larson, US
    • 15:00 - 15:10

      Quantitative Evaluation of a Novel Self-Management Education Program for COPD in the Context of Multi-Morbidity

      Speaker: Sameera Ansari, AU
    • 15:10 - 15:20

      Do Australian Community Pharmacists have a Role in COPD Case Finding?

      Speaker: Mariam Fathima, AU
  • Oral Presentations: Interstitial Lung Disease 2

    Room: E3.4
    • 14:00 - 14:10

      Clinicopathological Characteristics of Pulmonary-Limited Vasculitis

      Speaker: Sakae Homma, Japan
    • 14:10 - 14:20

      Increased Concentration of B Cell Activating Factors in the Patients with Autoimmune Pulmonary Alveolar Proteinosis

      Speaker: Masaki Hirose, Japan
    • 14:20 - 14:30

      Serum Levels of Anti-GM-CSF Autoantibody Reflected Disease Severity of Autoimmune Pulmonary Alveolar Proteinosis Followed up for Long-Term

      Speaker: Akiko Matsumuro, Japan
    • 14:30 - 14:40

      Evaluation for the Therapeutic Response by using a Quantitative Computed Tomographic Method in Pulmonary Alveolar Proteinosis

      Speaker: Miku Oda, Japan
    • 14:40 - 14:50

      The Diagnosis of Idiopathic Interstitial Pneumonias in a Real World; Nationwide Surveilance in Japan

      Speaker: Yoshikazu Inoue, Japan
    • 14:50 - 15:05

      Long-term clinical course of unclassifiable idiopathic interstitial pneumonia diagnosed by surgical lung biopsy

      Speaker: Erina Tabata, Japan
    • 15:05 - 15:15

      Chloromethylisothiazolinone and Methylisothiazoline Induces Lung Epithelial Cell Damage and Inflammatory Responses in Mouse Lung

      Speaker: Jooyeon Lee, South Korea
    • 15:15 - 15:25

      MUC4 Variable Number Tandem Repeat Polymorphisms and Severe Lung Injury

      Speaker: Jun Shiihara, Japan
  • 15:30 - 16:00

    Plenary Session: Closing Ceremony

    Room: Darling Harbour Theatre